These findings suggest that Deguelin and Rapamycin may cause KLK8 to functionally switch from being anti-apoptotic to pro-apoptotic in pancreatic cancer cells, a possibility that merits further investigation. Here, KLK8 is linked to pancreatic neoplasm.